I joined Alana Welm’s lab in 2018 as a postdoctoral fellow. My research goal is to develop personalized precision medicine for breast cancer patients. I am using a panel of breast cancer patient-derived organoid models to perform drug screening in a high-throughput manner, which allows prediction of cancer patient treatment response and identification of effective therapeutic compounds to improve patient care.
